IBB vs VCIT
iShares Biotechnology ETF vs Vanguard Intermediate-Term Corporate Bond ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
VCIT—
Vanguard Intermediate-Term Corporate Bond ETF
Intermediate-term investment-grade corporate bonds.
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | VCIT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
Holdings data unavailable for IBB.
VCIT top holdings
Holdings data unavailable for VCIT.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About VCIT
VCIT (Vanguard Intermediate-Term Corporate Bond ETF) is Intermediate-term investment-grade corporate bonds.